Adolescent and young adult oncology patients in France: Heterogeneity in pathways of care. Issue 9 (17th May 2018)

• Record Type: Journal Article
• Authors: Desandes, Emmanuel; Brugières, Laurence; Molinié, Florence; Defossez, Gautier; Delafosse, Patricia; Jehannin‐Ligier, Karine; Velten, Michel; Trétarre, Brigitte; Amadéo, Brice; Marrer, Emilie; Woronoff, Anne‐Sophie; Ganry, Olivier; Monnereau, Alain; d'Almeida, Tania; Troussard, Xavier; Daubisse‐Marliac, Laetitia; Bara, Simona; Guizard, Anne‐Valérie; Baldi, Isabelle; Launoy, Guy; Clavel, Jacqueline; Lacour, Brigitte
• Is Part Of: Pediatric blood & cancer. Volume 65:Issue 9(2018)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2018-05-17
• Subjects: adolescents -- cancer -- pathway of care -- young adults; Tumors in children -- Periodicals; Blood -- Diseases -- Periodicals; Cancer in children -- Periodicals; 618.92
• DOI: 10.1002/pbc.27235
• Languages: English
• ISSNs: 1545-5009

Abstract

Abstract: Background: In order to evaluate at the population level the impact of the actions developed in France since 2004 to organize the care of adolescents and young adults (AYAs) with cancer, we conducted the present study to provide an unbiased view of the pathway of care of these patients. Methods: Using a population‐based registry, we conducted a review of all cases of cancer diagnosed during 2012 and 2013 in 15‐ to 24‐year‐old patients living in nineteen French administrative areas. Results: The median times for diagnosis and treatment of the 993 included AYAs were 9 weeks (3–22) and 1 day (0–20), respectively. Delays in diagnosis were significantly longer in young adults than in adolescents, especially for soft‐tissue sarcomas (48.7 weeks vs. 15.4 weeks, P = 0.04) and bone tumors (21.4 weeks vs. 10.1 weeks, P = 0.04). The first physicians seen by patients were mostly general practitioners (67.4%). Most patients (77.5%) were treated in adult units. Management decisions were taken within the context of a multidisciplinary team (MDT) in 85.3% of cases. MDT meetings that involved both pediatric and adult oncologists were uncommon (15.7% of patients). Twenty‐six percent of patients were included in randomized or nonrandomized clinical studies. The proportion of inclusion was significantly higher in adolescents (39.5%) than in young adults (16.8%). Conclusion: In France, pathways of care for AYAs are heterogeneous. It is necessary to organize a national network of expert centers with adequate medical skills and specific psychosocial support and facilities to provide the best possible care for these patients.